無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

麻酔薬の世界市場の予測

Global Anesthesia Drug Market Size study, by Type, by Routes of Administration, by Product and Regional Forecasts 2018-2025

発行 Bizwit Research & Consulting LLP 商品コード 749560
出版日 ページ情報 英文 200 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.61円で換算しております。
Back to Top
麻酔薬の世界市場の予測 Global Anesthesia Drug Market Size study, by Type, by Routes of Administration, by Product and Regional Forecasts 2018-2025
出版日: 2018年11月21日 ページ情報: 英文 200 Pages
概要

当レポートでは、世界の麻酔薬市場について調査分析し、市場力学、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 世界の麻酔薬市場の定義と範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の麻酔薬市場力学

  • 成長の見通し
  • 産業分析
  • アナリストの提言と結論

第5章 世界の麻酔薬市場:種類別

  • 市場スナップショット
  • 市場実績:潜在的モデル
  • 二次セグメント分析
    • 一般麻酔
    • 脊椎麻酔
    • 抹消神経ブロック (PNB)
    • サドルブロック麻酔
    • 射角筋間ブロック麻酔
    • 経静脈局所麻酔

第6章 世界の麻酔薬市場:投与経路別

  • 市場スナップショット
  • 市場実績:潜在的モデル
  • 二次セグメント分析
    • 静脈麻酔
    • 吸入麻酔

第7章 世界の麻酔薬市場:製品別

  • 市場スナップショット
  • 市場実績:潜在的モデル
  • 二次セグメント分析
    • プロポフォール
    • セボフルラン
    • デスフルラン
    • レミフェンタニル
    • ミダゾラム
    • デクスメデトミジン
    • その他

第8章 世界の麻酔薬市場:地域別分析

  • 市場スナップショット
  • 北米
  • 欧州
  • アジア
  • ラテンアメリカ
  • その他

第9章 競合インテリジェンス

  • 企業の市場シェア
  • 主な市場戦略
  • 企業プロファイル
    • Astra Zeneca
    • Abott Laboratories
    • Baxter International Inc
    • Boehringer Ingelheim
    • エーザイ
    • Fresenius SE & Co KGAA
    • Hospira Inc
    • Mylan NV
    • Novartis
    • Par Pharmaceuticals Companies Inc
    • Piramal
    • Pfizer
    • Roche
    • Hikma Pharmaceuticals PLC
    • SAS Institute Inc
図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ANESTHESIA DRUGMARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ANESTHESIA DRUGMARKET
  • TABLE 3. GLOBAL ANESTHESIA DRUGMARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. GLOBAL ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
  • TABLE 8. GLOBAL ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
  • TABLE 9. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. GLOBAL ANESTHESIA DRUGMARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW ANESTHESIA DRUGMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL ANESTHESIA DRUGMARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL ANESTHESIA DRUGMARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL ANESTHESIA DRUGMARKET, KEY TRENDS 2016
  • FIG 5. GLOBAL ANESTHESIA DRUGMARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. GLOBAL ANESTHESIA DRUGMARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL ANESTHESIA DRUGMARKET, PEST ANALYSIS
  • FIG 8. GLOBAL ANESTHESIA DRUGMARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. GLOBAL ANESTHESIA DRUGMARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. GLOBAL ANESTHESIA DRUGMARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA ANESTHESIA DRUGMARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE ANESTHESIA DRUGMARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC ANESTHESIA DRUGMARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA ANESTHESIA DRUGMARKET 2015 & 2025 (USD BILLON)
  • FIG 36. GLOBAL ANESTHESIA DRUGMARKET, COMPANY MARKET SHARE ANALYSIS (2016)
目次

Global Anesthesia Drug Market to reach USD xxx billion by 2025.

Global Anesthesia Drug Market valued approximately USD xxx billion in 2017 is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2018-2025. The Anesthesia defined as the temporary condition of unconsciousness, loss of memory, lack of pain and muscle relaxation. In the medical terms the anesthesia has taken its pivotal place in the treatment of diseases and surgeries. In the present scenario, the rising aging population and enhancing medical utility of anesthesia drugs in the medical care and surgeries is anticipated to increase in the forthcoming years that means there will be immense demand of anesthesia drugs considering the global scenario. According to medical experts the risk of complications during anesthesia are boosted by the factors such as smoking, high blood pressure, diabetes, obstructive sleep arena and lung related to heart or lung related medical conditions, and drug allergies or the past reactions related to anesthesia. The routes of administration of anesthesia drugs market includes the injection and inhalation. The Injection way of the anesthesia drugs in majorly prevalent in the anesthesia drugs market. The Inhalation way is on the verge of development and growth as it is being studied for the innovations. In few cases both the routes of administration such as injection and inhalation are used together to anesthetize the patient or the individual. The Patient who is administered by these drugs results into loosing consciousness and does not feel the pain after and during surgery & then wakes up with the short term memory loss which is also known as amnesia. The Anesthesiologists in the medical world prefer to have the utility of one or more combination of drugs which directly depends on the physical condition of the patient and experience of the physician or surgeon who is intended to treat the individual. The Lack of healthcare facilities in the underdeveloped countries such as sub-saharan and African countries such as Botswana, Swaziland and Uganda the presence of few anesthetic nurses and experienced surgeons is restraining the growth of the anesthesia drug market. In the present scenario, there is a lack of precise or standard procedure or technique in anesthesia management .The high cost of health procedures and the branded drugs is a major challenge which is limiting the growth of the anesthesia drug market.

The regional analysis of Global Anesthesia Drug Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to be the dominating region over the forecast period 2018-2025.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type :

  • General Anesthesia
  • Spinal Anesthesia
  • Peripheral Nerve Block
  • Saddle Block Anesthesia
  • Interscalene Block
  • IV Regional Anesthesia

Routes of Administration Segment include:

  • Injection Market
  • Inhalation Market

Product Segment Include:

  • Propofol
  • Sevoflurane
  • Desflurane
  • Remifentanil
  • Midazolam
  • Dexmedetomidine
  • Others

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2015, 2016

Base year - 2017

Forecast period - 2018 to 2025

The leading market players mainly include-

  • ABBOTT LABORATORIES
  • BAXTER INTERNATIONAL PLC
  • NOVARTIS
  • MYLAN NV
  • HIKMA PHARMACEUTICALS PLC
  • OTHERS

Target Audience of the Global Anesthesia Drug Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Global Anesthesia Drug Market Definition and Scope

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Scope of The Study
  • 1.4. Years Considered for The Study
  • 1.5. Currency Conversion Rates
  • 1.6. Report Limitation

Chapter 2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Data Mining
    • 2.1.2. Analysis
    • 2.1.3. Market Estimation
    • 2.1.4. Validation
    • 2.1.5. Publishing
  • 2.2. Research Assumption

Chapter 3. Executive Summary

  • 3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
  • 3.2. Key Trends

Chapter 4. Global Anesthesia Drug Market Dynamics

  • 4.1. Growth Prospects
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Industry Analysis
    • 4.2.1. Porter's 5 Force Model
    • 4.2.2. PEST Analysis
    • 4.2.3. Value Chain Analysis
  • 4.3. Analyst Recommendation & Conclusion

Chapter 5. Global Anesthesia Drug Market, By Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Global Anesthesia Drug Market, Sub Segment Analysis
    • 5.3.1. General Anesthesia
      • 5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.2. Spinal Anesthesia
      • 5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.3. Peripheral Nerve Block
      • 5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.4. Saddle Block Anesthesia
      • 5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.5. Interscalene Block
      • 5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

    • 5.3.6. IV Regional Anesthesia Market
      • 5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Anesthesia Drug Market, By Routes of Administration

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Global Anesthesia Drug Market, Sub Segment Analysis
    • 6.3.1. Injection
      • 6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.2. Inhalation
      • 6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Anesthesia Drug Market, By Product

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Global Anesthesia Drug Market, Sub Segment Analysis
    • 7.3.1. Propofol
      • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.2. Sevoflurane
      • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.3. Desflurane
      • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.4. Remifentanil
      • 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.5. Midzalom
      • 7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.6. Dexmedetomidine
      • 7.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.7. Others
      • 7.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Global Anesthesia Drug Market, by Regional Analysis

  • 8.1. Anesthesia Drug Market, Regional Market Snapshot (2015-2025)
  • 8.2. North America Anesthesia Drug Market Snapshot
    • 8.2.1. U.S.
      • 8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.2.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.2.2. Canada
      • 8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.2.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 8.3. Europe Anesthesia Drug Market Snapshot
    • 8.3.1. U.K.
      • 8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.3.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.3.2. Germany
      • 8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.3.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.3.3. France
      • 8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.3.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.3.4. Rest of Europe
      • 8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.3.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 8.4. Asia Anesthesia Drug Market Snapshot
    • 8.4.1. China
      • 8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.4.2. India
      • 8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.4.3. Japan
      • 8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.4.4. Rest of Asia Pacific
      • 8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 8.5. Latin America Anesthesia Drug Market Snapshot
    • 8.5.1. Brazil
      • 8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.5.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.5.2. Mexico
      • 8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.5.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 8.6. Rest of The World
    • 8.6.1. South America
      • 8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.6.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.6.2. Middle East and Africa
      • 8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 8.6.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Competitive Intelligence

  • 9.1. Company Market Share (Subject to Data Availability)
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Astra Zeneca
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial (Subject to Data Availability)
      • 9.3.1.3. Product Summary
      • 9.3.1.4. Recent Developments
    • 9.3.2. Abott Laboratories
    • 9.3.3. Baxter International Inc
    • 9.3.4. Boehringer Ingelheim
    • 9.3.5. Eisai Co Ltd
    • 9.3.6. Fresenius SE & Co KGAA
    • 9.3.7. Hospira Inc
    • 9.3.8. Mylan NV
    • 9.3.9. Novartis
    • 9.3.10. Par Pharmaceuticals Companies Inc
    • 9.3.11. Piramal
    • 9.3.12. Pfizer
    • 9.3.13. Roche
    • 9.3.14. Hikma Pharmaceuticals PLC
    • 9.3.15. SAS Institute Inc
Back to Top